About
Eidostx is a healthcare company focused on research and insights related to transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and life-threatening heart disease caused by unstable transthyretin proteins leading to amyloid fibril buildup in the heart.
Explore Eidostx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.